. Introduction
tion of this neurohormonal response is an important target in preventing development of heart failure [1-3]. TreatThe neurohormonal activation after myocardial infarcment with angiotensin converting enzyme (ACE) inhibitors tion (MI) plays an important role in the development and and angiotensin II (AT II) type 1 receptor (AT1) blockers progression of adverse cardiac remodeling. The modulahas been shown to inhibit cardiac hypertrophy, preserve cardiac function, and attenuate changes in myocardial gene expression in experimental MI models [4] . The beneficial *Corresponding author. Tel.: 1358-9-477-0040; fax: 1358-9-4770-effect of renin-angiotensin system blockade on survival 0425 . E-mail address: ilkka.tikkanen@helsinki.fi (I. Tikkanen). 1 These authors contributed equally to this article. Time for primary review 18 days.
after MI has also been demonstrated in multiple clinical ceuticals (Princeton, NY, USA). The drugs under study trials [5, 6] .
were mixed to powdered rat chow. The doses were Myocardial remodeling after MI includes compensatory selected according to our earlier dose-response work [28] hypertrophy of the cardiac myocytes [7] [8] [9] , but also an and targeted at omapatrilat 40 mg / kg per day, SQ-28603 increase in interstitial collagen deposition [10] . Transition 100 mg / kg per day, and captopril 100 mg / kg per day. The from compensatory hypertrophy to progressive dilatation actual consumed doses were omapatrilat 39 mg / kg per and heart failure is mediated at least partly by the day, SQ-28603 88 mg / kg per day and captopril 109 continuous loss of myocytes due to apoptosis [11] [12] [13] [14] . In mg / kg per day. experimental MI models myocardial apoptosis has been shown to continue at a high level not only in the areas adjacent to the infarction zone, but also in the more remote 2 .3. Study outline areas of the left ventricle (LV) [15] [16] [17] . This can be due to pressure overload [18] and neurohormonal factors, both of
The animals were acclimated to powdered rat chow which have been demonstrated to induce apoptosis in the without medication for 5 days. Daily food and water heart. AT II is a direct trigger of apoptosis of ventricular consumption were determined throughout the study. The myocytes in vitro [19] . However, it is unclear whether body weights were recorded before starting medication, post-MI apoptosis can be prevented by ACE-inhibitors or before operation and 1 and 4 weeks after MI operation. even more effectively by inhibiting neutral endopeptidase
The animals were randomised to the treatment groups 24 h (NEP).
before the MI operation to cover also the acute and The objective of this study was to investigate the effects subacute phases of infarction. The medication had no of combined ACE and NEP inhibition on adverse myocareffect on the size of the infarction, since there was no dial remodeling and apoptosis after MI. We used omapatdifference in the infarcted area between the groups as rilat, a single molecule that simultaneously inhibits both measured by planimetry at 1 or 4 weeks after the opera-NEP and ACE [20] . NEP inhibition protects atrial nattion. MI was produced by ligation of the left anterior riuretic peptide (ANP), B-type natriuretic peptide (BNP) descending coronary artery as described earlier [15, 29] . and related peptides from enzymatic inactivation [21] and
The control rats underwent the same procedure, except for thus preserves the vasodilatory, natriuretic, diuretic [20] , the ligation of the coronary artery (sham operation). and antihypertrophic effects of these peptides [22] . ConSystolic blood pressure (SBP) was measured before startcurrent ACE inhibition blocks AT II formation and ing the medication, 1 and 4 weeks after operation by tail increases bradykinin levels [23] [24] [25] . The co-inhibition of cuff plethysmography in conscious lightly restrained ani-NEP and ACE has been shown to produce greater haemomals. Echocardiography was carried out in all animals 4 dynamic and renal effects than inhibition of either NEP or weeks after operation. The animals were sacrificed 1 or 4 ACE alone in several models of heart failure and hypertenweeks after operation. Hearts that showed no histological sion [26, 27] . Our hypothesis was that omapatrilat would signs of infarction were not included in the study. There have greater anti-apoptotic and anti-remodeling effects were seven rats in each omapatrilat and captopril group, compared with the selective inhibitors of ACE or NEP in 6-8 rats in SQ-28603 groups and 10 rats in vehicle control the rat MI model. groups. [31, 32] . The optical densities were quantified by an AIDA were identified by the presence of myofilaments surroundcomputer image analyzing system (AIDA 2D densitoming the nucleus. The amounts of apoptotic cardiomyocytes etry) coupled to the FUJIFILM BAS-5000 phosphoimager were expressed as the proportion of TUNEL-positive (Tamro, Finland). Specific binding was calculated as total cardiomyocyte nuclei from the total number of carbinding minus non-specific binding. diomyocyte nuclei, obtained by multiplying the density of cardiomyocyte nuclei in a serial Dnase I-treated control 2 .6. Histology and planimetry of infarct size section times the area of the section [11, 15, 35] .
. Methods
The presence of signs of either acute MI or collagen scars was analyzed under microscope by examination of 2 .10. Echocardiography Van Gieson-stained transverse LV sections. Infarct size was determined planimetrically as the ratio of infarcted tissue Prior to echocardiography, the animals were sedated by  or scar to the length of the entire LV endocardial circummedetomidine 0.25 mg / kg (Domitor , Orion Pharma, ference. Infarcts were classified as small (10-30%), modEspoo, Finland) given subcutaneously and placed on a erate (31-49%) or large (.50%). There were no statistithermal plate. Two-dimensional echocardiographic meacally significant differences in infarct sizes between the surements were carried out using a 7-10 MHz phased groups.
array sector probe (Toshiba Power Vision 8000, Toshiba Medical Systems, Nasu, Japan) from the right parasternal 2 .7. BNP mRNA
projection. An average of three measurements was used to assess LV end diastolic diameter (LVEDD), LV anterior BNP mRNA expression was determined both from the wall thickness, and posterior wall thickness (PW). LV end border zone of MI and from the remote area of the LV. diastolic volume (LVEDV) was measured by Simpson's  Total RNA was prepared with the QuickPrep system formula. LV mass was calculated from a standard cube (Amersham-Pharmacia Biotech, Uppsala, Sweden) and the formula and relative PW thickness (2*PW/ LVEDD) as cDNA first strand was synthesized using M-MuLV reverse described [36] . The coefficient of variation was 3.3% for transcriptase. The quantitative PCR reactions were carried LVEDD, 8.7% for PW, and 7.9% for LVEDV, respectively. out with an ABI 7700 Sequence Detection System using  TaqMan chemistry. The forward and reverse primers for 2 .11. Statistical methods rat BNP mRNA detection were TGGGCAGAAGATA-GACCGGA and ACAACCTCAGCCCGTCACAG, Results are presented as mean6S.E.M. unless otherwise corresponding to nucleotides 300-319 and 361-342 of stated. Data were analyzed using analysis of variance rat BNP cDNA coding sequence, respectively. The (ANOVA) including infarction size (MI%) as a covariate 62 bp amplicon was detected using the bifunctional where appropriate. If statistical significance was obtained fluorogenic probe 59-Famீ-CCAAGCGACTGACTbetween groups, Fisher's protected least significance test GCGCCG-Tamraீ-39. The results were normalized to 18S was used to determine where significant differences ex-RNA quantified from the same samples as described isted. Blood pressure measurements were analyzed using previously [33] .
repeated measures ANOVA. A difference at P,0.05 was considered statistically significant.
.8. Myocardial fibrosis
The interstitial collagen volume fraction (CVF) was determined from three different slices of picrosirius red 3 . Results (Fluka)-stained LV sections under polarized light. Areas of connective tissue network and myocytes were quantified 3 .1. Body weight, systolic blood pressure, and hormonal by a semiautomated computer-based analysis system as parameters described by Brooks et al. [34] .
3 .1.1. Body weight 2 .9. Apoptosis
There was no statistical difference in the body weight between the groups either before the operation or after the Apoptotic cardiomyocytes were detected with the termi-4-week treatment period (Table 1) . Values are given as mean6S.E.M. PRA, plasma renin activity; NT-ANP, N-terminal natriuretic peptide; BNP, B-type natriuretic peptide. *Vehicle1MI versus Treatment1MI. **P,0.01, ***P,0.001.
.1.2. Blood pressure
treated rats (P,0.001). SQ-28603 had no effect on PRA. Mean SBP before starting the medication was 129
There were no significant differences in plasma N-terminal mmHg. One week after MI, SBP was lower in the ANP or BNP levels between any of the treatment groups. omapatrilat (9167 mmHg, P,0.01) and captopril (9765 mmHg, P,0.05) treated groups compared to the selective 3 .1.4. ACE and NEP autoradiography NEP inhibitor (11365 mmHg), but there was no signifi-ACE and NEP inhibitions from kidney samples were cant difference by comparison with the vehicle MI group.
analyzed by quantitative autoradiography [26, 32] to conFour weeks after the operation SBP was lowest in the trol the effectiveness of drug administration. The renal omapatrilat group, but there was no significant difference ACE autoradiography signal was 22% higher after 4 weeks compared to the captopril or vehicle-treated rats (Fig. 1) .
in vehicle MI rats compared with sham-operated rats, but the difference was not statistically significant. There was 3 .1.3. Hormonal effects no change in NEP autoradiography signal levels after MI Treatment with captopril but not with omapatrilat inin vehicle-treated rats. Omapatrilat showed inhibition of creased significantly PRA (Table 1) . PRA level in captopboth ACE and NEP (remaining activities 3065%, P, ril-treated rats was sevenfold compared to control MI rats 0.001 and 3666%, P,0.001, respectively, Table 1 ). SQ-(P,0.001) and over 2.5-fold compared to omapatrilat-28602 inhibited NEP (3663%, P,0.001), but had no effect on ACE (9464%). Captopril had no inhibitory effect on renal NEP (9867%), but inhibited renal ACE (7164%, P,0.01).
.2. Hypertrophy, BNP gene expression and fibrosis
3 .2.1. Heart weight A compensatory increase in the relative heart weight was detected 4 weeks after MI in non-treated rats (P,0.01, Fig. 2A ). At 1 week there were no differences in relative cardiac weights between the groups. However, 4 weeks after operation relative cardiac weights were significantly smaller in the omapatrilat (3.060.2 mg / g, P,0.01) and SQ-28603 (3.360.2 mg / g, P,0,05) treated groups compared to control MI rats (3.960.3 mg / g) (Fig. 2B) . Also as measured by echocardiography, LV mass was significantly lower in the omapatrilat-treated group compared to captopril and control MI groups (Table 2) .
.2.2. BNPmRNA
LV hypertrophy after MI involves the hypertrophic growth of cardiomyocytes and the accumulation of fibrillar collagen in the interstitium. As a marker of hypertrophic weeks the expression was lower in the omapatrilat and captopril-treated rats. The reduced BNP mRNA expression was detected both in border zone and remote areas (Fig.  3B) . Instead, in the SQ-28603-treated group there were no statistical differences in BNP mRNA levels compared to the vehicle-treated MI group in either area.
.2.3. Myocardial fibrosis
To estimate the interstitial component of the hypertrophy, we measured the levels of fibrosis from the LV tissue sections 4 weeks after the operation. CVF was determined from the non-infarcted area by quantitative morphometry. Myocardial fibrosis increased after MI. In the sham operated animals, CVF in the LV was 1.960.4%, whereas in the vehicle MI group, CVF was 4.860.9% (P,0.001) (Fig. 4) . Both omapatrilat and captopril treatments decreased CVF compared to the vehicle-treated group (2.860.2%, P,0.01 and 2.860.7%, P,0.01, respectively). Selective NEP inhibition by SQ-28603 did not have any effect on fibrosis.
.3. Apoptosis and left ventricular dilatation

.3.1. Cardiomyocyte apoptosis
Apoptosis increased after MI both in the border zone and in the remote area. The apoptosis was 3.6-fold higher in the border zone compared with the remote area 4 weeks after MI. The percentage of apoptotic cardiomyocytes in the myocardium of sham operated rats was 0.0160.002% (Fig. 5 ) and remained stable from 1 to 4 weeks. In the border zone areas of vehicle-treated infarctions, the percentage of apoptotic cells decreased from 0.18 to 0.13% (P50.34) from 1 to 4 weeks. In the remote noninfarcted myocardium, apoptosis increased from 0.014% at 1 week to 0.035% at 4 weeks (P,0.05).
Both omapatrilat and captopril treatments decreased the number of apoptotic myocytes in LV tissue sections. After 1 week the level of apoptosis in the border zone area of MI was 0.14% with captopril-treated rats and 0.13% with omapatrilat-treated rats compared to 0.18% in vehicletreated MI rats, but the difference was not statistically P,0.05, respectively). In contrast, the amount of apoptosis in the SQ-28603-treated animals did not differ from the sham group (Fig. 3A) . In the vehicle MI group BNP control MI group 4 weeks after the operation. mRNA expression was 3.7-fold higher in the border zone LV dilatation after MI was evaluated by transthoracic and 1.5-fold higher in the remote zone 4 weeks after echocardiography. The echocardiographically measured operation compared to the sham group. There were no LV dimensions are summarized in Table 2 . LV dilatation significant differences in the expression of BNP mRNA was observed 4 weeks after operation as the LVEDDs and between the medicated groups 1 week after MI, but after 4
LVEDVs were significantly larger in the vehicle MI group when compared to sham operated rats, but there were no 4 . Discussion significant differences between the different MI treatment groups. However relative wall thickness decreased sigOur results indicate that omapatrilat was more effective nificantly both in omapatrilat and SQ-28603-treated rats than captopril in preventing cardiac hypertrophy after compared with the vehicle MI rats (Table 2) .
experimental MI in rats. Omapatrilat as well as captopril reduced hypertrophic gene expression and had an antifibrotic effect, whereas SQ-28603 had no effect. Both omapatrilat and captopril treatments inhibited cardiomyocyte apoptosis.
.1. Hemodynamic and hormonal effects of ACE /NEP inhibition
The objective of this study was to compare dual ACE / NEP inhibitor omapatrilat to selective ACE and NEP inhibitors, captopril and SQ-28603, respectively, in a rat MI model. Omapatrilat is the most clinically developed vasopeptidase inhibitor [37] . It produces a balanced inhibition of NEP and ACE in vivo [28] , but has no effect on other related enzymes [38] . Both preclinical studies as well as clinical trials have shown that omapatrilat is effective in treating heart failure and it is suggested to have greater impact on morbidity and mortality than selective ACE inhibitors alone [39] [40] [41] [42] .
One of the adverse effects of the selective ACE inhibition is the compensatory increase in PRA. This increase may partially damp the beneficial hemodynamic and antihypertrophic effects of ACE inhibitors. In our study, captopril treatment induced an increase in PRA similar to what has been reported earlier [43] . However, despite the ACE inhibitory component of omapatrilat, PRA was not significantly increased in omapatrilat-treated animals compared with the animals treated with vehicle. The lack of the compensatory activation of the renin-angiotensin system may be explained by NEP inhibition, because enhanced action of natriuretic peptides has been reported to inhibit renin synthesis [44] . hypertrophy [45, 46, 4] . In our study, BNP mRNA in the border zone of infarction was already clearly increased 1 that another vasopeptidase inhibitor S21402 reduced the week after the MI operation in vehicle-treated rats. After 4 mass of both ventricles of the heart after MI [43] . In that weeks, an increase in BNP mRNA was also detected in the study captopril regressed LV mass, selective NEP inhibitor remote noninfarcted area. Omapatrilat and also to a lesser SCH42495 regressed right ventricular mass and the comextent captopril significantly decreased BNP mRNA exbined effect of these drugs was equal to the cardiac mass pression both in the border zone and in the remote area of reduction caused by the vasopeptidase inhibitor S21402. In myocardium 4 weeks after MI. Selective NEP inhibition another study, candesartan and cilazapril both significantly did not affect the BNP mRNA expression.
prevented the increase in heart weight at 4 weeks after MI In accordance with the decreased BNP expression, operation [47] . omapatrilat treatment reduced relative cardiac weights as
In our experimental setting, ACE inhibition alone did well as echocardiographically measured LV mass compared not cause significant changes in cardiac weight, which may to vehicle-treated rats. It has been previously demonstrated depend on the relatively short follow-up time. Slightly lower SBP levels with omapatrilat may contribute to the fibrosis after MI. Collagen deposition during healing of the better antihypertrophic effect. Omapatrilat is an effective MI is central for preserving the strength of the infarcted inhibitor of cardiac ACE as demonstrated by our earlier in area [49, 50] . However, the accumulation of interstitial vitro autoradiography findings [28] and this may also fibrosis to the noninfarcted area is associated with the explain the more effective reduction in heart mass by development of hypertrophy and may have a negative omapatrilat compared to captopril treatment. Inhibition of effect on the diastolic function of the heart [51] . The NEP may also reduce hypertrophy by increasing autocrine renin-angiotensin system is an important regulator not and paracrine actions of natriuretic peptides, as a selective only of cardiomyocyte hypertrophy but also of interstitial NEP inhibitor, SCH42495, reduced LV hypertrophy with matrix. AT II stimulates cardiac fibroblast collagen synminimal effects on blood pressure [48] .
thesis via the AT1 receptor in vitro [52] , and both ACE inhibition and AT1 blockade have been shown to inhibit 4 .3. Effect of ACE /NEP inhibition on myocardial the interstitial accumulation of collagen after MI and in fibrosis hypertensive heart disease [51, 53] . NEP inhibition reduces degradation of natriuretic pepBoth omapatrilat and captopril reduced myocardial tides, which are known to have an antifibrotic effect by the stimulation of their A-and B-type receptors [54] . ACE and A cknowledgements NEP also act as potent kinin-degrading enzymes in plasma and tissues [55, 56] and accordingly, plasma and tissue We wish to acknowledge Terhi Suvanto and Tuulä bradykinin levels are increased during ACE / NEP inhibiRiihimaki for excellent technical assistance. This study tion [57] . Kinins have been shown to contribute to the was supported by the Research Grants of Helsinki Unireduction of myocardial collagen accumulation by ACE versity Central Hospital, the Sigrid Juselius Foundation, inhibition after MI [58] . Farina et al. [59] have shown that and Bristol-Myers Squibb Pharmaceutical Research Instidual NEP/ACE inhibitor S21402 inhibited cardiac fibrosis tute. M.L. and E.P. were supported by personal grants from in spontaneously hypertensive rats. Both captopril and Paavo Nurmi Foundation and T.B. from von Frenckell's selective NEP inhibitor treatments had antifibrotic effects.
Foundation. In the present work, the antifibrotic effect was similar with both omapatrilat and captopril. However, we found no inhibition of the fibrosis with the selective NEP inhibitor R eferences SQ-28603 alone. induced during hypoxia [60] and ischemia-reperfusion in myocardium [61] . Apoptosis is also activated in human border zones of infarct scars in a dog model of ischemic
